PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTriamcinolone acetonide
Triamcinolone acetonide
Aristocort, Kenacort, Kenalog, Mytrex A, Nasacort, Triamcinolone, Triderm, Triesence, Xipere, Zilretta (triamcinolone acetonide) is a small molecule pharmaceutical. Triamcinolone acetonide was first approved as Aristocort on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA. It is known to target glucocorticoid receptor.
Download report
Favorite
BMS
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
musculoskeletal diseasesD009140
digestive system diseasesD004066
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
nervous system diseasesD009422
eye diseasesD005128
urogenital diseasesD000091642
hemic and lymphatic diseasesD006425
hereditary congenital and neonatal diseases and abnormalitiesD009358
Show 7 more
Trade Name
FDA
EMA
Triamcinolone (discontinued: Triamcinolone)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Triamcinolone acetonide
Tradename
Company
Number
Date
Products
TRIAMCINOLONE ACETONIDEMylanN-011601 DISCN1982-01-01
2 products, RLD
TRIAMCINOLONE ACETONIDERising PharmaceuticalsN-011600 DISCN1982-01-01
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
24 hour nasal allergyANDA2025-06-09
allergy nasalANDA2024-11-22
allernazeNew Drug Application2010-11-23
basic care nasal allergyANDA2022-10-13
blt-25 kitunapproved drug other2024-09-11
bupivilog kitunapproved drug other2024-12-31
bupivilog procedure kitNew Drug Application2014-01-30
calcipotriene 0.005% / triamcinolone acetonide 0.1%unapproved drug other2019-05-10
careone allergy reliefANDA2023-10-23
cortaren corticosteroid/anti-inflammatory systemANDA2022-02-24
Show 79 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
atopic dermatitisEFO_0000274D003876L20
ulcerative colitisEFO_0000729D003093K51
ankylosing spondylitisEFO_0003898D013167M45
nephrotic syndromeEFO_0004255D009404N04
multiple sclerosisEFO_0003885D009103G35
uveitisEFO_1001231D014605H20.9
inflammationMP_0001845D007249—
pulmonary tuberculosisEFO_1000049D014397A15
adrenal insufficiency—D000309—
systemic lupus erythematosusEFO_0002690D008180M32
Show 17 more
Agency Specific
FDA
EMA
Expiration
Code
TRIAMCINOLONE ACETONIDE, XIPERE, BAUSCH AND LOMB INC
2024-10-22NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Triamcinolone Acetonide, Xipere, Bausch And Lomb Inc
99370752034-05-02DP
96363322033-11-08U-3234
86367132027-05-02U-3234
Triamcinolone Acetonide, Zilretta, Pacira Pharms Inc
88284402031-08-04DP
95550482031-08-04U-2151
Triamcinolone Acetonide, Triesence, Novartis
81289602029-12-17DP
82118802029-03-10U-1257, U-1258
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AC: Corticosteroids for local oral treatment
— A01AC01: Triamcinolone
C: Cardiovascular system drugs
— C05: Vasoprotectives
— C05A: Agents for treatment of hemorrhoids and anal fissures for topical use
— C05AA: Corticosteroids, topical for treatment of hemorrhoids and anal fissures
— C05AA12: Triamcinolone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AB: Corticosteroids, moderately potent (group ii)
— D07AB09: Triamcinolone
— D07B: Corticosteroids, combinations with antiseptics
— D07BB: Corticosteroids, moderately potent, combinations with antiseptics
— D07BB03: Triamcinolone and antiseptics
— D07C: Corticosteroids, combinations with antibiotics
— D07CB: Corticosteroids, moderately potent, combinations with antibiotics
— D07CB01: Triamcinolone and antibiotics
— D07X: Corticosteroids, other combinations
— D07XB: Corticosteroids, moderately potent, other combinations
— D07XB02: Triamcinolone
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB08: Triamcinolone
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD11: Triamcinolone
— R03: Drugs for obstructive airway diseases
— R03B: Other drugs for obstructive airway diseases, inhalants in atc
— R03BA: Glucocorticoid inhalants for obstructive airway disease
— R03BA06: Triamcinolone
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA05: Triamcinolone
— S02: Otologicals
— S02C: Corticosteroids and antiinfectives in combination, otologic
— S02CA: Corticosteroids and antiinfectives in combination
— S02CA04: Triamcinolone and antiinfectives
HCPCS
Code
Description
J3300
Injection, triamcinolone acetonide, preservative free, 1 mg
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
J3304
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Clinical
Clinical Trials
1056 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atopic dermatitisD003876EFO_0000274L20——1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTriamcinolone acetonide
INNtriamcinolone
Description
Triamcinolone acetonide is a synthetic glucocorticoid that is the 16,17-acetonide of triamcinolone. Used to treat various skin infections. It has a role as an anti-inflammatory drug and an anti-allergic agent. It is an 11beta-hydroxy steroid, a 20-oxo steroid, a 21-hydroxy steroid, a 3-oxo-Delta(4) steroid, a glucocorticoid, a cyclic ketal, a fluorinated steroid and a primary alpha-hydroxy ketone. It is functionally related to a triamcinolone. It derives from a hydride of a pregnane.
Classification
Small molecule
Drug classsteroids (not prednisolone derivatives); topical steroids (acetal derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
Identifiers
PDB—
CAS-ID76-25-5
RxCUI—
ChEMBL IDCHEMBL1504
ChEBI ID71418
PubChem CID6436
DrugBankDB00620
UNII IDF446C597KA (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Zilretta – Pacira BioSciences
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zilretta – Flexion Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 13,674 documents
View more details
Safety
Black-box Warning
Black-box warning for: Blt-25 kit, Bupivilog kit, Mlk f1 kit, Mlk f3 kit, Mlk f4 kit, Mlk kit f2
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
20,694 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use